This webinar will highlight recent findings of the ROPAD study and introduce the design principles of the newly launched ROPAD consortium to foster collaboration and accelerate treatments for Parkinson's disease.
The Rostock International Parkinson's Disease Study (ROPAD) is a global observational study focusing on the role of genetics in Parkinson's disease. The major goal of the study is to characterize the genetics of Parkinson's disease to establish a better understanding of the disease progression, diagnosis, and treatment.
Throughout this study, up to 25,000 Parkinson's disease participants from around the world will be tested. In this webinar, discover how registries and consortium approaches are pivotal in driving Parkinson's disease efforts to accelerate treatment access.
Specifically, expert speakers will discuss the ROPAD study and its evolution, and how it can serve multiple purposes, such as:
- Genetic screening diagnostics
- Protocol trial design
- Observational follow up of Parkinson's disease patients to gather patient experiences and outcomes that are central to research and regulatory decision-making in Parkinson's disease
A must watch for industry leaders working in the field of Parkinson's disease, patient advocacy groups, non-profit Parkinson's disease institutions and CROs running Parkinson's disease trials.
What you will learn:
- Current Parkinson’s disease initiatives and unmet needs in studies
- Perspective from leading patient advocacy group on challenges in the Parkinson’s research space
- ROPAD recent study results
- ROPAD consortium design principles and benefit to the patient community
Save Your Seat Today!
You won't want to miss this inside look into RODAP consortium.
